Results 171 to 180 of about 683,865 (337)
Neuroimaging for differential diagnosis of transient neurological attacks
Abstract Background Rapid yet comprehensive neuroimaging protocols are required for patients with suspected acute stroke. However, stroke mimics can account for approximately one in five clinically diagnosed acute ischemic strokes and the rate of thrombolyzed mimics can be as high as 17%.
Ying Wang, Hao Zha
wiley +1 more source
THE RELATIONSHIP OF INFECTING DOSAGE, LEUCOCYTIC RESPONSE, BACTEREMIA, AND EXTENT OF PULMONARY INVOLVEMENT TO THE OUTCOME OF EXPERIMENTAL LOBAR PNEUMONIA IN THE DOG [PDF]
O. H. Robertson, John P. Fox
openalex +1 more source
COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2
Abstract Introduction This review highlights the potential mechanisms of neuromuscular manifestation of COVID‐19, especially myasthenia gravis (MG). Methods An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020. Results Exacerbations of clinical symptoms
Syed Muhammad Ismail Shah+10 more
wiley +1 more source
Abstract Background Treatment options for Chinese patients with locally advanced or metastatic squamous‐cell non‐small‐cell lung cancer (sqNSCLC) after failure of first‐line chemotherapy are limited. This study (ORIENT‐3) aimed to evaluate the efficacy and safety of sintilimab versus docetaxel as second‐line treatment in patients with locally advanced ...
Yuankai Shi+45 more
wiley +1 more source
Pneumonia in North-West London, 1942-4: I. Bacterial Pneumonias [PDF]
Jean H. Humphrey+2 more
openalex +1 more source
On Variations in the Phagocytic and Coccidal Power of the Blood in Pneumonia and Scarlet Fever [PDF]
R. Tunnicliff
openalex +1 more source
STUDIES UPON EXPERIMENTAL PNEUMONIA IN RABBITS [PDF]
B. S. Kline, M. C. Winternitz
openalex +1 more source
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source